1. Home
  2. TOVX vs GITS Comparison

TOVX vs GITS Comparison

Compare TOVX & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • GITS
  • Stock Information
  • Founded
  • TOVX 2001
  • GITS 2018
  • Country
  • TOVX United States
  • GITS South Korea
  • Employees
  • TOVX N/A
  • GITS N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • GITS
  • Sector
  • TOVX Health Care
  • GITS
  • Exchange
  • TOVX Nasdaq
  • GITS Nasdaq
  • Market Cap
  • TOVX 3.8M
  • GITS 3.4M
  • IPO Year
  • TOVX 2006
  • GITS N/A
  • Fundamental
  • Price
  • TOVX $0.47
  • GITS $2.02
  • Analyst Decision
  • TOVX Hold
  • GITS
  • Analyst Count
  • TOVX 1
  • GITS 0
  • Target Price
  • TOVX N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • TOVX 1.8M
  • GITS 2.9M
  • Earning Date
  • TOVX 05-14-2025
  • GITS 07-15-2025
  • Dividend Yield
  • TOVX N/A
  • GITS N/A
  • EPS Growth
  • TOVX N/A
  • GITS N/A
  • EPS
  • TOVX N/A
  • GITS N/A
  • Revenue
  • TOVX N/A
  • GITS N/A
  • Revenue This Year
  • TOVX N/A
  • GITS N/A
  • Revenue Next Year
  • TOVX N/A
  • GITS N/A
  • P/E Ratio
  • TOVX N/A
  • GITS N/A
  • Revenue Growth
  • TOVX N/A
  • GITS N/A
  • 52 Week Low
  • TOVX $0.40
  • GITS $0.87
  • 52 Week High
  • TOVX $7.37
  • GITS $9.78
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 29.91
  • GITS N/A
  • Support Level
  • TOVX $0.43
  • GITS N/A
  • Resistance Level
  • TOVX $0.54
  • GITS N/A
  • Average True Range (ATR)
  • TOVX 0.05
  • GITS 0.00
  • MACD
  • TOVX 0.03
  • GITS 0.00
  • Stochastic Oscillator
  • TOVX 41.18
  • GITS 0.00

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: